Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

What carcinoembryonic antigen (CEA) level should trigger further investigation during colorectal cancer follow-up?

ABSTRACT: Study hypothesis: It is feasible to increase the sensitivity of blood CEA as an indicator of recurrent colorectal cancer while retaining an acceptable level of specificity by specifying a positive result in terms of the change in blood CEA level over time rather than the absolute level of a single measurement. Pilot study on http://www.isrctn.com/ISRCTN61091474 Main trial on http://www.isrctn.com/ISRCTN41458548 Primary outcome(s): The main outcomes (cancer recurrence, treatment of recurrence with curative intent, and death) are monitored continuously. Blood CEA levels are measured 3 monthly for 2 years and 6 monthly for the next 3 years.

DISEASE(S): Colorectal Cancer Follow-up

PROVIDER: 2426259 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Exon Level Expression Profiling analysis of early stage NSCLC suffering rapidly relapse

Project description:Postoperative recurrence is the main cause of poor prognosis in early stage lung adenocarcinoma (LUAD). Factors that can predict recurrence risk are critically needed.we designed a screening procedure based on gene profile data.The differentially expressed genes (DEGs) between patients with recurrence-free survival (RFS)<1 year and RFS>3 years were found.Cox proportional hazards model, IHC and Kaplan-Meier survival analysis were preformed to validate these biomarkers in TCGA and Daping validation sets.

2018-10-27 | GSE121841 | GEO

Differences of miRMA expression signitures for blood samples of children with high blood lead level and low blood lead level

Project description:To further explore the effect of blood lead on miRNA expression in blood, children (aged 2-5 years) from kindergartens of Shaanxi province were divided into two groups and blood samples were collected. miRNA array was used to testify miRNA expression landscape between low blood lead level (BLL) group (0~ 50.00 g/L) and high BLL group (>50.00 g/L).Our data showed that 27 miRNAs were highly differentially expressed. Expression of miR-34b from this signiture was quantified by qRT-PCR,linear regression analysis showed that the correlation coefficient between blood lead level and miR-34b is 0.247, p <0.001, indicating that miR-34b was correlated with BLL.

2021-11-27 | GSE189490 | GEO

tRNA level in HeLa, CFBE41o- and primary HBE cells

Project description:Comparison of overall tRNA level between HeLa, cystic fibrosis (CF) bronichal epithelial (CFBE41o-) cells and primary CF patient derived human bronchial epithelial (HBE) cells, estimation of absolute HeLa tRNA levels.

2017-05-24 | GSE53991 | GEO

Genome-wide transcriptome analysis of the brain (ventral part of telenchephalon, hypothalamus and pituitary) of medaka (Oryzias latipes) kept under outdoor natural conditions over a period of two years

Project description:Expression profile of the brain (ventral part of telenchephalon, hypothalamus and pituitary) of medaka (Oryzias latipes) kept under outdoor natural conditions were obtained by RNA-seq analysis. Monthly transcriptomes for two years identified 3,341 seasonally-oscillating genes.

2023-12-19 | GSE234401 | GEO

Differences of miRMA expression signitures for blood samples of children with high blood lead level and low blood lead level

Project description:Differences of miRMA expression signitures for blood samples of children with high blood lead level and low blood lead level

| PRJNA783266 | ENA

Development of a two-circular RNA panel as potential prognostic biomarker for gastric cancer

Project description:Background: Circular RNAs (circRNAs) have attracted increasing attention in recent years for their potential application as disease biomarkers due to their high abundance and stability. In this study, we attempted to screen circRNAs that can be used to predict postoperative recurrence and survival in patients with gastric cancer (GC). Methods: High-throughput RNA sequencing was used to identify differentially expressed circRNAs in GC patients with different prognoses. The expression level of circRNAs in the training set (n=136) and validation set (n=167) was detected by quantitative real-time PCR (qRT-PCR). Kaplan–Meier estimator, receiver operating characteristic (ROC) curve and cox regression analysis were used to evaluate the prognostic value of circRNAs on recurrence-free survival (RFS) and overall survival (OS) in GC patients. CeRNA network prediction, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed for the circRNAs with prognostic significance. Results: A total of 259 differentially expressed circRNAs were identified in GC patients with different RFS. We found two circRNAs (hsa_circ_0005092 and hsa_circ_0002647) that highly expressed in GC patients with good prognoses, and subsequently established a predictive model for postoperative recurrence and prognosis evaluation, named circPanel. Patients with circPanellow might have shorter recurrence-free survival (RFS) and overall survival (OS). We also performed circRNA-miRNA-mRNA network prediction and functional analysis for hsa_circ_0005092 and hsa_circ_0002647. Conclusions: CircPanel has the potential to be a prognostic biomarker in GC patients with greater accuracy than a single circRNA and certain traditional tumor markers (e.g., CEA, CA19-9 and CA724).

2021-08-12 | GSE181769 | GEO

RNA-seq analysis of blood transcriptomes from managed bottlenose dolphins in Waikoloa, Hawaii, USA

Project description:Whole blood was collected as part of monthly veterinary checkups of bottlenose dolphins housed at Dolphing Quest in Waikoloa, Hawaii, USA. Gene expression from 5 samples was analyzed for comparison to the blood transcriptome of the beluga whale.

2017-05-09 | GSE98627 | GEO

Peripheral blood cells expression data form 7 patients with severe pdm(H1N1) influensa and 7 gender and age matched healthy controls

Project description:Using PAXgene tubes, peripheral blood samples were collected from seven patients >18 years with documented pdm(H1N1) influenza, bilateral chest infiltrates, and in need of ventilation support. Significant co-morbidity was exclusion criterion. Expression profiles were compared with 7 age matched controls. Using a false discovery rate < 5% and an absolute fold change > 2, 370 genes were differentially expressed in case and controls. A second sample was collected after ca 6 days in the 7 patients and temporal changes in expression profiles investigated. Over expressed putative mediators of inflammatory lung dammage were measured on the protein level. 14 patient samples (7 paired samples) and 7 control samples were performed.

2011-04-01 | E-GEOD-27131 | biostudies-arrayexpress

Peripheral blood cells expression data form 7 patients with severe pdm(H1N1) influensa and 7 gender and age matched healthy controls

2011-04-01 | GSE27131 | GEO

The role of nucleosome positioning in the evolution of gene regulation

Project description:This SuperSeries is composed of the following subset Series: GSE22191: Absolute expression level of Debaryomyces hansenii genes GSE22192: Absolute expression level of Yarrowia lipolytica genes GSE22193: Absolute expression level of Saccharomyces paradoxus genes GSE22194: Absolute expression level of Candida glabrata genes GSE22197: Absolute expression level of Candida albicans genes GSE22198: Absolute expression level of Kluyveromyces lactis genes GSE22199: Absolute expression level of Kluyveromyces waltii genes GSE22200: Absolute expression level of Saccharomyces castellii genes GSE22201: Absolute expression level of Saccharomyces mikatae genes GSE22202: Absolute expression level of Saccharomyces kluyveryii genes GSE22204: Absolute expression level of Saccharomyces cerevisiae genes GSE22205: Absolute expression level of Saccharomyces bayanus genes GSE22211: Genome-wide nucleosome position data for 12 yeast species Refer to individual Series

2010-07-05 | E-GEOD-21960 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data